2022-11-01 2023-10-31 false Capium Accounts Production 1.1 12253565 bus:FullAccounts 2022-11-01 2023-10-31 12253565 bus:FRS102 2022-11-01 2023-10-31 12253565 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 12253565 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 12253565 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 12253565 2022-11-01 2023-10-31 12253565 2023-10-31 12253565 bus:RegisteredOffice 2022-11-01 2023-10-31 12253565 core:WithinOneYear 2023-10-31 12253565 core:AfterOneYear 2023-10-31 12253565 bus:Director1 2022-11-01 2023-10-31 12253565 bus:Director1 2023-10-31 12253565 bus:Director1 2021-11-01 2022-10-31 12253565 2021-11-01 12253565 bus:LeadAgentIfApplicable 2022-11-01 2023-10-31 12253565 2021-11-01 2022-10-31 12253565 2022-10-31 12253565 core:WithinOneYear 2022-10-31 12253565 core:AfterOneYear 2022-10-31 12253565 bus:EntityAccountantsOrAuditors 2021-11-01 2022-10-31 12253565 core:FurnitureFittings 2022-11-01 2023-10-31 12253565 core:FurnitureFittings 2023-10-31 12253565 core:FurnitureFittings 2022-10-31 12253565 core:ComputerEquipment 2022-11-01 2023-10-31 12253565 core:ComputerEquipment 2023-10-31 12253565 core:ComputerEquipment 2022-10-31 12253565 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-10-31 12253565 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-10-31 12253565 core:CostValuation core:Non-currentFinancialInstruments 2023-10-31 12253565 core:CostValuation core:Non-currentFinancialInstruments 2022-10-31 12253565 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-10-31 12253565 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-10-31 12253565 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-10-31 12253565 core:Non-currentFinancialInstruments 2023-10-31 12253565 core:Non-currentFinancialInstruments 2022-10-31 12253565 core:ShareCapital 2023-10-31 12253565 core:ShareCapital 2022-10-31 12253565 core:RetainedEarningsAccumulatedLosses 2023-10-31 12253565 core:RetainedEarningsAccumulatedLosses 2022-10-31 12253565 dpl:Item1 2022-11-01 12253565 dpl:Item1 2023-10-31 12253565 dpl:Item1 2021-11-01 12253565 dpl:Item1 2022-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12253565
England and Wales

 

 

 

OAK MEDICAL SCIENCE LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 November 2022

End date: 31 October 2023
Director Simon Guy
Registered Number 12253565
Registered Office C/O Melanie Curtis Accountants Ltd
100 Berkshire Place
Winnersh, Wokingham
Berkshire
RG41 5RD
1
Director's report and financial statements
The director presents his annual report and the financial statements for the year ended 31 October 2023.
Principal activities
Principal activity of the company during the financial year was of other professional, scientific and technical activities not elsewhere classified.
Director
The director who served the company throughout the year was as follows:
Simon Guy

On behalf of the board.


----------------------------------
Simon Guy
Director

Date approved: 12 August 2024
2
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3   1,272 
  1,272 
Current assets      
Debtors 4 589    589 
Cash at bank and in hand 86,661    88,929 
87,250    89,518 
Creditors: amount falling due within one year 5 (8,690)   (8,428)
Net current assets 78,560    81,090 
 
Total assets less current liabilities 78,560    82,362 
Provisions for liabilities 6   (137)
Net assets 78,560    82,225 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 78,460    82,125 
Shareholders' funds 78,560    82,225 
 


For the year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 12 August 2024 and were signed by:


-------------------------------
Simon Guy
Director
3
General Information
Oak Medical Science Ltd is a private company, limited by shares, registered in England and Wales, registration number 12253565, registration address C/O Melanie Curtis Accountants Ltd , 100 Berkshire Place, Winnersh, Wokingham, Berkshire , RG41 5RD.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102"The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.

Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and Fittings 3 Straight Line
Computer Equipment 3 Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees


Average number of employees during the year was 0 (2022 : 0).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Computer Equipment   Total
  £   £   £
At 01 November 2022 180    2,668    2,848 
Additions    
Disposals (180)   (2,668)   (2,848)
At 31 October 2023    
Depreciation
At 01 November 2022 100    1,476    1,576 
Charge for year 40    596    636 
On disposals (140)   (2,072)   (2,212)
At 31 October 2023    
Net book values
Closing balance as at 31 October 2023    
Opening balance as at 01 November 2022 80    1,192    1,272 


4.

Debtors: amounts falling due within one year

2023
£
  2022
£
Taxation recoverable 589    589 
589    589 

5.

Creditors: amount falling due within one year

2023
£
  2022
£
Accrued Expenses 1,200    1,000 
Directors' Current Accounts 7,490    7,428 
8,690    8,428 

6.

Provisions for liabilities

2023
£
  2022
£
Deferred Tax   137 
  137 

4